169 related articles for article (PubMed ID: 36927350)
21. Different phenotype relapse of myeloid/lymphoid neoplasms with FGFR1 rearrangement with long remission.
Sugiyama M; Arakawa A; Kogure Y; Shirakawa N; Watanabe M; Ito Y; Tanimura K; Tao K; Nakajima M; Watanabe Y; Miyagi-Maeshima A; Fukuhara S; Kataoka K; Izutsu K; Fukuda T; Ogawa C
Pediatr Blood Cancer; 2024 Jan; 71(1):e30721. PubMed ID: 37833848
[No Abstract] [Full Text] [Related]
22. Myeloid/lymphoid neoplasm with a novel cryptic
Yang T; Mahmood N; Goldberg B; Cevallos J; Hsu P; Kolitz J; Cohen N; Zhang X
Leuk Lymphoma; 2023 Dec; 64(14):2338-2342. PubMed ID: 37791611
[No Abstract] [Full Text] [Related]
23. Molecular monitoring of 8p11 myeloproliferative syndrome in an infant.
Zhang WW; Habeebu S; Sheehan AM; Naeem R; Hernandez VS; Dreyer ZE; López-Terrada D
J Pediatr Hematol Oncol; 2009 Nov; 31(11):879-83. PubMed ID: 19829149
[TBL] [Abstract][Full Text] [Related]
24. Clinical Response to Upfront Targeted Tyrosine Kinase Inhibitors among Patients with Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusion.
Zhang Y; Nguyen L; Lu CM; Wang E; Lauw MIS; Ball S; Dong N; Moscinski L; Chan O; Yun S; Sallman D; Sokol L; Shah B; Knepper T; Lancet J; Komrokji R; Padron E; Kuykendall A; Zhang L
Clin Lymphoma Myeloma Leuk; 2023 Mar; 23(3):e150-e163. PubMed ID: 36624015
[TBL] [Abstract][Full Text] [Related]
25. Functional characterization, localization, and inhibitor sensitivity of the TPR-FGFR1 fusion in 8p11 myeloproliferative syndrome.
Malli T; Buxhofer-Ausch V; Rammer M; Erdel M; Kranewitter W; Rumpold H; Marschon R; Deutschbauer S; Simonitsch-Klupp I; Valent P; Muellner-Ammer K; Sebesta C; Birkner T; Webersinke G
Genes Chromosomes Cancer; 2016 Jan; 55(1):60-8. PubMed ID: 26391436
[TBL] [Abstract][Full Text] [Related]
26. Acute myeloid leukemia associated with FGFR1 abnormalities.
Lee H; Kim M; Lim J; Kim Y; Han K; Cho BS; Kim HJ
Int J Hematol; 2013 Jun; 97(6):808-12. PubMed ID: 23609419
[TBL] [Abstract][Full Text] [Related]
27. 8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), CEP110/FGFR1 fusion transcript: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality.
Park TS; Song J; Kim JS; Yang WI; Song S; Kim SJ; Suh B; Choi JR
Cancer Genet Cytogenet; 2008 Mar; 181(2):93-9. PubMed ID: 18295660
[TBL] [Abstract][Full Text] [Related]
28. Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2.
Pozdnyakova O; Orazi A; Kelemen K; King R; Reichard KK; Craig FE; Quintanilla-Martinez L; Rimsza L; George TI; Horny HP; Wang SA
Am J Clin Pathol; 2021 Feb; 155(2):160-178. PubMed ID: 33367495
[TBL] [Abstract][Full Text] [Related]
29. Myeloid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, and FGFR1: a review.
Savage N; George TI; Gotlib J
Int J Lab Hematol; 2013 Oct; 35(5):491-500. PubMed ID: 23489324
[TBL] [Abstract][Full Text] [Related]
30. 8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways.
Guasch G; Ollendorff V; Borg JP; Birnbaum D; Pébusque MJ
Mol Cell Biol; 2001 Dec; 21(23):8129-42. PubMed ID: 11689702
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in Japan.
Usuki K; Kameda T; Kawano N; Ito T; Hashimoto Y; Shide K; Kawano H; Sekine M; Toyama T; Iizuka H; Sato S; Takeuchi M; Ishizaki J; Maeda K; Nakai M; Yamashita K; Kubuki Y; Shimoda K
Int J Hematol; 2024 Jun; 119(6):722-727. PubMed ID: 38457113
[TBL] [Abstract][Full Text] [Related]
32. Acute leukemia with cytogenetically cryptic FGFR1 rearrangement and lineage switch during therapy: A case report and literature review.
McKeague SJ; O'Rourke K; Fanning S; Joy C; Throp D; Adams R; Harvey Y; Keng TB
Am J Clin Pathol; 2024 Feb; 161(2):197-205. PubMed ID: 37855739
[TBL] [Abstract][Full Text] [Related]
33. Proteomic analysis reveals dual requirement for Grb2 and PLCγ1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation.
Peiris MN; Meyer AN; Warda D; Campos AR; Donoghue DJ
Oncotarget; 2022; 13():659-676. PubMed ID: 35574218
[TBL] [Abstract][Full Text] [Related]
34. Molecular identification of a TPR-FGFR1 fusion transcript in an adult with myeloproliferative neoplasm, T-lymphoblastic lymphoma, and a t(1;8)(q25;p11.2).
Kim SY; Kim JE; Park S; Kim HK
Cancer Genet; 2014 Jun; 207(6):258-62. PubMed ID: 25037443
[TBL] [Abstract][Full Text] [Related]
35. Chromosome 8p11.2 translocations: prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution.
Patnaik MM; Gangat N; Knudson RA; Keefe JG; Hanson CA; Pardanani A; Ketterling RP; Tefferi A
Am J Hematol; 2010 Apr; 85(4):238-42. PubMed ID: 20143402
[TBL] [Abstract][Full Text] [Related]
36. Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib.
Landberg N; Dreimane A; Rissler M; Billström R; Ågerstam H
Eur J Haematol; 2017 Nov; 99(5):442-448. PubMed ID: 28881484
[TBL] [Abstract][Full Text] [Related]
37. Cytogenetic Evolution Associated With Disease Progression in Hematopoietic Neoplasms With t(8;22)(p11;q11)/BCR-FGFR1 Rearrangement.
Wang W; Tang G; Kadia T; Lu X; Li Y; Huang L; Montenegro-Garreaud X; Miranda RN; Wang SA
J Natl Compr Canc Netw; 2016 Jun; 14(6):708-11. PubMed ID: 27283163
[TBL] [Abstract][Full Text] [Related]
38. 8p11 myeloproliferative syndrome: a review.
Jackson CC; Medeiros LJ; Miranda RN
Hum Pathol; 2010 Apr; 41(4):461-76. PubMed ID: 20226962
[TBL] [Abstract][Full Text] [Related]
39. [Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1].
Fan XS; Wang SA
Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):779-83. PubMed ID: 23302345
[No Abstract] [Full Text] [Related]
40. [Myeloid/lymphoid neoplasms with eosinophilia and FGFR1 rearrangement: 5 cases report and literatures review].
Liu YT; Zhao JW; Feng J; Li QH; Chen YM; Qiu LG; Xiao ZJ; Li Y; Gong BF; Gong XY; Mi YC; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2019 Oct; 40(10):848-852. PubMed ID: 31775485
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
